This Week at FDA: Speedy Drug Review Bonuses, Makary Defends Prasad, and MoreFebruary 27, 2026February 28, 2026
This Week at FDA: QMSR and PreCheck Kickoff, Makary Tries to Ease CNPV Concerns, and MoreFebruary 6, 2026February 9, 2026
This Week at FDA: CDRH Annual Report, Partial Shutdown Update, and MoreJanuary 30, 2026February 5, 2026
This Week at FDA: HHS Ends Aborted Fetal Tissue Research, PreCheck Pilot Update, and MoreJanuary 23, 2026February 5, 2026
This Week at FDA: Drug Voucher Program Hits a Snag, GOP Targets Abortion Drug, and MoreJanuary 16, 2026January 17, 2026
FDA and EMA Release Guiding Principles of Good AI Practice in Drug DevelopmentJanuary 14, 2026January 14, 2026
This Week at FDA: FDA Eases Digital Health Oversight, MDUFA Negotiation Update, and MoreJanuary 9, 2026January 14, 2026
